On Wednesday, Shares of Microsoft Corporation (NASDAQ:MSFT), lost -0.45% to $46.68. 24.69 million shares of the company were exchanged.
The stock is up 2.54% in this year through last close, and the beta ratio has a value of 0.90. The stock, as of recent close, has shown weekly downbeat performance of -0.26% which was maintained at 6.14% in 1-month period.
Five days after Microsoft Corp. opened preorders for its first-ever laptop, the Surface Book has sold out, according to Market Watch.
The 13.5-inch device, which Microsoft has contrast to Apple Inc.’s AAPL, -1.41% Macbook Pro, headlined Microsoft’s product event on Oct. 6 and right away went on sale on the company’s website.
Five days later, the purchase button has been replaced by an “email me when available” option, indicating all Surface Book versions, ranging from $1,499 to $2,099, are presently out of stock. Market Watch Reports
Microsoft Corporation, a technology company, develops, licenses, and supports software products, services, and devices worldwide. The company’s Devices and Consumer (D&C) Licensing segment licenses Windows operating system and related software; Microsoft Office for consumers; and Windows Phone operating system. Its Computing and Gaming Hardware segment provides Xbox gaming and entertainment consoles and accessories, second-party and third-party video games, and Xbox Live subscriptions; surface devices and accessories; and Microsoft PC accessories.
Shares of Zafgen Inc (NASDAQ:ZFGN), surged 23.81% to $19.50, during its last trading session.
Zafgen, Inc. (ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, recently issued the following statement:
“Zafgen recently learned of a patient death which occurred in the Company’s ongoing double-blind, randomized, placebo-controlled Phase 3 bestPWS study of beloranib in Prader-Willi Syndrome, a rare genetic disorder with a high rate of mortality linked to obesity and its co-morbidities. The cause of death remains unknown at this time. According to normal practice, the event was stated to the U.S. Food and Drug Administration, at which point the Agency initiated a talk about with the Company. The Company is working with the Agency to expedite a review and understanding of this event, and to determine implications of the event on the conduct of the trial, and anticipates providing an update as its talk about with the Agency progress. The thoughts of the Company are with the family of the patient at this time. Zafgen remains committed to ensuring the safety of all patients enrolled in its studies.”
Zafgen, Inc., a biopharmaceutical company, focuses on the development of therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate comprises Beloranib, an injection, which is in Phase III clinical trials for the treatment of obesity and hyperphagia in Prader-Willi Syndrome patients; that has accomplished Phase II clinical trials for the treatment of hypothalamic injury-associated obesity, counting craniopharyngioma-associated obesity; and which is in Phase IIb clinical trials for the treatment of severe obesity in the general population.
Finally, Shares of Boeing Co (NYSE:BA), ended its last trade with -4.37% loss, and closed at $134.16.
Boeing [NYSE:BA] is seeing a noteworthy uptick in China traffic as the government eases travel restrictions and moves toward a service-based economy, even as the Chinese economy grows at its slowest pace in more than 20 years, according to Bloomberg.
“We see no slowdown in traffic domestically, traffic regionally, and actually see an uptick, noteworthy internationally, especially as the Chinese government has changed policies around visas,” Randy Tinseth, vice president of marketing at Boeing Commercial Airplanes, said in a Bloomberg Television interview Thursday.
Boeing has declared plans for the company’s first facility in China, as it predicts the country will displace the U.S. as the world’s largest aircraft and travel market over the next two decades. Travel to and from China has received a boost from relaxed visa requirements to China and as higher disposable income lets more Chinese travel overseas. Bloomberg Reports
The Boeing Company, together with its auxiliaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight, and launch systems and services worldwide. The company operates in five segments: Commercial Airplanes, Boeing Military Aircraft, Network & Space Systems, Global Services & Support, and Boeing Capital.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
